Ali M, Chaudhary B, Panja S, Gendelman H
Results Probl Cell Differ. 2024; 73:551-578.
PMID: 39242393
DOI: 10.1007/978-3-031-62036-2_22.
Zhao L, Zhang T, Zhang K
Front Immunol. 2024; 15:1353614.
PMID: 38698858
PMC: 11064651.
DOI: 10.3389/fimmu.2024.1353614.
Lee Y, Pan Y, Lim D, Park S, Sin S, Kwack K
Int J Mol Sci. 2024; 25(3).
PMID: 38338927
PMC: 10855752.
DOI: 10.3390/ijms25031650.
Jahani-Sherafat S, Azimirad M, Raeisi H, Azizmohammad Looha M, Tavakkoli S, Ahmadi Amoli H
Mol Biol Rep. 2024; 51(1):265.
PMID: 38302841
DOI: 10.1007/s11033-024-09273-3.
Borras D, Verbandt S, Ausserhofer M, Sturm G, Lim J, Verge G
Cell Discov. 2023; 9(1):114.
PMID: 37968259
PMC: 10652011.
DOI: 10.1038/s41421-023-00605-4.
A Narrative Literature Review on Sepsis: A Primary Manifestation of Colorectal Neoplasm.
Masood L, Muller A, Ali N, Mummadisetty A, Yahya A, Burugu S
Cureus. 2023; 15(9):e44803.
PMID: 37809261
PMC: 10560076.
DOI: 10.7759/cureus.44803.
A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target.
Fernandez-Murga M, Gil-Ortiz F, Serrano-Garcia L, Llombart-Cussac A
Pathogens. 2023; 12(9).
PMID: 37764894
PMC: 10535898.
DOI: 10.3390/pathogens12091086.
Individualized network analysis reveals a link between the gut microbiome, diet intervention and Gestational Diabetes Mellitus.
Liu Y, Amit G, Zhao X, Wu N, Li D, Bashan A
PLoS Comput Biol. 2023; 19(6):e1011193.
PMID: 37384793
PMC: 10337958.
DOI: 10.1371/journal.pcbi.1011193.
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity.
Mahdy M, Azmy A, Dishisha T, Mohamed W, Ahmed K, Hassan A
BMC Microbiol. 2023; 23(1):53.
PMID: 36864380
PMC: 9979425.
DOI: 10.1186/s12866-023-02791-3.
A phylogenetic review of cancer resistance highlights evolutionary solutions to Peto's Paradox.
Nery M, Renno M, Picorelli A, Ramos E
Genet Mol Biol. 2022; 45(3 Suppl 1):e20220133.
PMID: 36534348
PMC: 9762133.
DOI: 10.1590/1678-4685-GMB-2022-0133.
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S, Singh R, Vanwinkle Z, Guo H, Vemula P, Goel A
Theranostics. 2022; 12(12):5574-5595.
PMID: 35910798
PMC: 9330515.
DOI: 10.7150/thno.70754.
Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.
Jiang T, Yang T, Chen Y, Miao Y, Xu Y, Jiang H
Theranostics. 2022; 12(6):2833-2859.
PMID: 35401838
PMC: 8965491.
DOI: 10.7150/thno.70719.
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker O, Liu C, Wu W, Wong S, Jia W, Sung J
Microbiome. 2022; 10(1):35.
PMID: 35189961
PMC: 8862353.
DOI: 10.1186/s40168-021-01208-5.
The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer.
Kovacs T, Miko E, Ujlaki G, Yousef H, Csontos V, Uray K
Cancer Metastasis Rev. 2021; 40(4):1223-1249.
PMID: 34967927
PMC: 8825384.
DOI: 10.1007/s10555-021-10013-3.
The pathogenic oral-gut-liver axis: new understandings and clinical implications.
Imai J, Kitamoto S, Kamada N
Expert Rev Clin Immunol. 2021; 17(7):727-736.
PMID: 34057877
PMC: 8416698.
DOI: 10.1080/1744666X.2021.1935877.
Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids.
Park M, Kwon J, Shin H, Moon S, Kim S, Shin U
Int J Oncol. 2020; 57(6):1307-1318.
PMID: 33173975
PMC: 7646587.
DOI: 10.3892/ijo.2020.5132.
Intestinal Microbiota in Colorectal Cancer Surgery.
Koliarakis I, Athanasakis E, Sgantzos M, Mariolis-Sapsakos T, Xynos E, Chrysos E
Cancers (Basel). 2020; 12(10).
PMID: 33081401
PMC: 7602998.
DOI: 10.3390/cancers12103011.
The Mechanism of Toxin Contributes to Colon Cancer Formation.
Cheng W, Kantilal H, Davamani F
Malays J Med Sci. 2020; 27(4):9-21.
PMID: 32863742
PMC: 7444842.
DOI: 10.21315/mjms2020.27.4.2.
Immunity to commensal skin fungi promotes psoriasiform skin inflammation.
Hurabielle C, Link V, Bouladoux N, Han S, Merrill E, Lightfoot Y
Proc Natl Acad Sci U S A. 2020; 117(28):16465-16474.
PMID: 32601220
PMC: 7368261.
DOI: 10.1073/pnas.2003022117.
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q, Wang K, Wu W, Lv L, Bian X, Yang L
Appl Microbiol Biotechnol. 2020; 104(13):5915-5928.
PMID: 32367312
DOI: 10.1007/s00253-020-10621-z.